People: Albireo Pharma Inc (ALBO.OQ)
Dr. Anne Klibanski M.D. is the Independent Director of Albireo Pharma Inc. Dr. Klibanski has served as a member of our board of directors since June 2018. Dr. Klibanski has served as Chief Academic Officer of Partners HealthCare since March 2012, where she oversees Partners-wide academic programs in research and education. In February 2019, Dr. Klibanski was named interim President and Chief Executive Officer of Partners HealthCare. Dr. Klibanski has also served as Chief, Neuroendocrine Unit at Massachusetts General Hospital since 1989 and as the Laurie Carrol Guthart Professor of Medicine at Harvard Medical School since 2009. She is a leader in the field of neuroendocrine disorders and pituitary tumors. The author of over 350 papers and chapters, she has received numerous awards, including the Endocrine Society Clinical Investigator Award and the Clinical Endocrinology Trust Medal from the British Endocrine Society and has served as a member of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Board of Counselors. Dr. Klibanski holds a B.A. from Barnard College and an M.D. from New York University School of Medicine.
|Total Annual Compensation, USD||21,823|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||371,025|
|Fiscal Year Total, USD||392,848|